(Q42807342)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014761%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Tunicamycin potentiates drug cytotoxicity and vincristine retention in multidrug resistant cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014761%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

main subject

multiple drug resistance

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014761%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

D Hiss

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014761%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P Jacobs

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014761%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P Folb

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014761%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014761%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014761%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

32A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014761%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014761%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

2164-2172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9014761%20AND%20SRC:MED&resulttype=core&format=json

Clinical studies with modulators of multidrug resistance.

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Drug-stimulated ATPase activity of the human P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Effects of lipids on ATPase activity of purified Chinese hamster P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Membrane transport in multidrug resistance, development, and disease. AACR special conference in cancer research

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Cellular transport of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Correlation between the short-term measurements of drug accumulation in living cells and the long-term growth inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Influx of daunorubicin in multidrug resistant Ehrlich ascites tumour cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Detection of soluble P-glycoprotein in culture media and extracellular fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Dissecting glycoprotein biosynthesis by the use of specific inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Stability and covalent modification of P-glycoprotein in multidrug-resistant KB cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Response of malignant and nonmalignant epidermal cell lines to tunicamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

The role of N-linked glycosylation in the regulation of activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and proliferation of SV40-transformed 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Relationships among dolichyl phosphate, glycoprotein synthesis, and cell culture growth

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Isoprenoids and astroglial cell cycling: Diminished mevalonate availability and inhibition of dolichol-linked glycoprotein synthesis arrest cycling through distinct mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

From amplification to function: the case of the MDR1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Membrane glycoprotein changes associated with anthracycline resistance in HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

P-glycoproteins encoded by mdr 1b in murine gravid uterus and multidrug resistant tumor cell lines are differentially glycosylated

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Mevalonate is essential for growth activation of human fibroblasts: evidence for a critical role of protein glycosylation in the prereplicative period

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

The preparation of tritiated tunicamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Mechanisms of multidrug resistance in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Accumulation of cis-diamminedichloroplatinum (II) and its analogues in sensitive and resistant human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Reversal of Cisplatin Resistance with Amphotericin B in a Non-small Cell Lung Cancer Cell Line

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Combination therapy with cisplatin and nifedipine inducing apoptosis in multidrug-resistant human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Distinct P-glycoprotein expression in two subclones simultaneously selected from a human colon carcinoma cell line by cis-diamminedichloroplatinum (II).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

The role of topoisomerase II in drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Design of DNA intercalators to overcome topoisomerase II-mediated multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021

Multidrug resistance associated with altered topoisomerase II activity--topoisomerases II as targets for rational drug design.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900262-6

7 January 2021